Literature DB >> 11581110

Depressive disorders in Europe: prevalence figures from the ODIN study.

J L Ayuso-Mateos1, J L Vázquez-Barquero, C Dowrick, V Lehtinen, O S Dalgard, P Casey, C Wilkinson, L Lasa, H Page, G Dunn, G Wilkinson.   

Abstract

BACKGROUND: This is the first report on the epidemiology of depressive disorders from the European Outcome of Depression International Network (ODIN) study. AIMS: To assess the prevalence of depressive disorders in randomly selected samples of the general population in five European countries.
METHOD: The study was designed as a cross-sectional two-phase community study using the Beck Depression inventory during Phase 1, and the Schedule for Clinical Assessment in Neuropsychiatry during Phase 2.
RESULTS: An analysis of the combined sample (n=8.764) gave an overall prevalence of depressive disorders of 8.56% (95% CI 7.05-10.37). The figures were 10.05% (95% CI 7.80-12.85) for women and 6.61% (95% CI 4.92-8.83) for men. The centres fall into three categories: high prevalence (urban Ireland and urban UK), low prevalence (urban Spain) and medium prevalence (the remaining sites).
CONCLUSIONS: Depressive disorder is a highly prevalent condition in Europe. The major finding is the wide difference in the prevalence of depressive disorders found across the study sites.

Entities:  

Mesh:

Year:  2001        PMID: 11581110     DOI: 10.1192/bjp.179.4.308

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  113 in total

1.  Adjustment disorders: prevalence in a representative nationwide survey in Germany.

Authors:  Andreas Maercker; Simon Forstmeier; Laura Pielmaier; Lena Spangenberg; Elmar Brähler; Heide Glaesmer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-03-11       Impact factor: 4.328

2.  From epidemiology to intervention for depressive disorders in the general population: the ODIN study.

Authors:  Christopher Dowrick; José Luis Ayuso-Mateos; José Luis Vazquez-Barquero; Graham Dunn; Odd Steffen Dalgard; Ville Lehtinen; Patricia Casey; Clare Wilkinson; Helen Page; Lourdes Lasa; Erin E Michalak; Greg Wilkinson
Journal:  World Psychiatry       Date:  2002-10       Impact factor: 49.548

3.  Features associated with the non-participation and drop out by socially-at-risk children and adolescents in mental-health epidemiological studies.

Authors:  Rosario Granero Pérez; Lourdes Ezpeleta; José María Domenech
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-02-01       Impact factor: 4.328

4.  [Over-diagnosis and over-treatment of major depressive disorder in primary care. An increasing phenomenon].

Authors:  Jaime Adán-Manes; José Luis Ayuso-Mateos
Journal:  Aten Primaria       Date:  2009-11-06       Impact factor: 1.137

5.  Sexual activity, sexual dysfunction and associated help-seeking behaviours in middle-aged and older adults in Spain: a population survey.

Authors:  Edson D Moreira; Dale B Glasser; Clive Gingell
Journal:  World J Urol       Date:  2005-12-08       Impact factor: 4.226

6.  Adjustment disorders: the state of the art.

Authors:  Patricia Casey; Susan Bailey
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

7.  Evaluation of major depression in a routine clinical assessment.

Authors:  Marco André Urbach Mezzasalma
Journal:  Diabetol Metab Syndr       Date:  2010-01-28       Impact factor: 3.320

8.  Pharmacotherapy of psychiatric inpatients with adjustment disorder: current status and changes between 2000 and 2016.

Authors:  Timo Greiner; Beatrice Haack; Sermin Toto; Stefan Bleich; Renate Grohmann; Frank Faltraco; Martin Heinze; Michael Schneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-08-22       Impact factor: 5.270

9.  Mental illness in a rural area: a Norwegian psychiatric epidemiological study.

Authors:  Einar Kringlen; Svenn Torgersen; Victoria Cramer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-05-26       Impact factor: 4.328

Review 10.  Escitalopram: a pharmacoeconomic review of its use in depression.

Authors:  Katherine F Croom; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.